Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Alternative Sunitinib Schedules

PURPOSE: To identify sunitinib alternative schedules (AS) that maintained dose intensity while decreasing adverse events (AEs) in patients with metastatic renal cell cancer (mRCC), and to determine impact of AS on clinical outcomes. PATIENTS AND METHODS: A retrospective review of patients ≥ 18 yr of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Atkinson, Bradley J., Kalra, Sarathi, Wang, Xuemei, Bathala, Tharakeswara, Corn, Paul, Tannir, Nizar M., Jonasch, Eric
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015627/
https://ncbi.nlm.nih.gov/pubmed/24018239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2013.08.090
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk